Eficur

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

ceftiofur

Available from:

Hipra New Zealand Limited

INN (International Name):

ceftiofur

Composition:

ceftiofur 50 g/litre

Therapeutic area:

Antibiotic

Authorization status:

ACVM Registered

Authorization date:

2011-10-03

Summary of Product characteristics

EFICUR
October 2021
LEAFLET
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
CRITICALLY IMPORTANT ANTIBIOTIC
EFICUR
SUSPENSION FOR INJECTION FOR CATTLE AND SWINE
CEFTIOFUR 50 MG/ML (AS CEFTIOFUR HYDROCHLORIDE)
USE CLAIMS:
Infections associated with bacteria sensitive to ceftiofur:
SWINE:
-
Treatment
of
swine
bacterial
respiratory
disease
associated
with
_Pasteurella_
_multocida, _
_Actinobacillus _
_pleuropneumoniae, _
_Salmonella _
_choleraesuis, _
and
_Strepotcoccus suis_
type 2
_._
CATTLE:
-
Treatment of bacterial respiratory disease (BRD) associated with
_Mannheimia_
_haemolytica, Pasteurella multocida _
and
_ Histophilus somni._
-
Treatment
of
acute
interdigital
necrobacillosis
(foot
rot)
associated
_ _
with
_Fusobacterium necrophorum and Prevotella melaninogenica._
-
Acute metritis (0 - 14 days after calving) associated with
_ _
bacterial organisms
susceptible to ceftiofur.
DIRECTIONS FOR USE:
SWINE:
3mg ceftiofur / kg bw (1mL EFICUR / 16kg bw) daily for 3 days by
intramuscular
injection
CATTLE:
Administer by IM or SC injection in the anterior half of the neck.
Treatment of respiratory disease (BRD) and footrot:
1mg ceftiofur / kg bw (1mL EFICUR per 50kg bw) every 24 hours for 3
days.
Additional treatments should be given on days 4 and 5 for cattle that
do not respond
after the first 3 treatments.
Acute post-partum metritis:
2.2 mg ceftiofur / kg bw (2.2mL EFICUR per 50kg bw) daily for 5
consecutive days.
Subsequent injections must be given at different sites.
In case of acute post-partum metritis, additional supportive therapy
might be required
in some cases.
No more than 10mL of EFICUR should be injected per injection site.
Shake the bottle well before use to bring the product back into
suspension. In the case
of 250 mL glass vial, remove the protector before shaking. The
coloration of the glass
vial may not be uniform making it difficult to determine when the
product is in
suspension. Following the shaking the absence of sediment can be
confirmed most
readily by inve